Key Takeaways & Executive Findings
- •• Optimizing layer height, extrusion temperature, and printing speed improves tensile strength by up to 32% and flexural strength by 28% in 3D-printed CFRP composites. • Reduced void content and enhanced fiber-matrix adhesion are key microstructural factors contributing to improved mechanical properties. • The study establishes a process-property relationship that enables tailored manufacturing of CFRP parts for structural applications. • The optimal parameter set offers a practical benchmark for industrial adoption of FFF-based CFRP production.
Abstract
This study investigates the influence of key process parameters on the mechanical properties of continuous carbon fiber reinforced polymer (CFRP) composites fabricated via fused filament fabrication (FFF). A systematic experimental design was employed to evaluate the effects of layer height, extrusion temperature, and printing speed on tensile strength, flexural strength, and interlaminar shear strength. The results indicate that optimizing these parameters can significantly enhance the mechanical performance, with an optimal combination yielding a 32% increase in tensile strength and a 28% improvement in flexural strength compared to baseline. Microstructural analysis revealed improved fiber-matrix adhesion and reduced void content in optimized samples. The findings provide practical guidelines for the additive manufacturing of high-performance CFRP components.
1. Introduction
Additive manufacturing (AM) has revolutionized the production of complex geometries, and continuous carbon fiber reinforced polymer (CFRP) composites have gained attention for their high strength-to-weight ratio. Fused filament fabrication (FFF) is a widely used AM technique, but the mechanical properties of printed CFRP parts are often inferior to those of conventionally manufactured composites due to process-induced defects. This study aims to systematically investigate the influence of critical process parameters on the mechanical performance of FFF-printed CFRP composites.
Previous research has explored the effects of individual parameters, but a comprehensive understanding of their interactions is lacking. This work employs a design of experiments approach to optimize layer height, extrusion temperature, and printing speed, and evaluates the resulting tensile, flexural, and interlaminar shear properties. The findings are expected to provide valuable insights for process optimization and quality control in additive manufacturing of CFRP components.
Loading authentic research manuscript (Pages 1–5)...
J. Zhang, L. Wang, M. Chen, R. Liu (2026). Enhancing the Mechanical Properties of 3D-Printed Continuous Carbon Fiber Reinforced Polymer Composites via Process Parameter Optimization. Chinese Journal of New Drugs. https://doi.org/10.1007/s12289-025-01845-7
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the optimal process parameters for 3D-printed CFRP composites?
The optimal parameters identified in this study are a layer height of 0.15 mm, extrusion temperature of 260°C, and printing speed of 30 mm/s, which resulted in the highest mechanical properties.
How does layer height affect the mechanical properties of 3D-printed CFRP?
Smaller layer heights generally improve interlaminar bonding and reduce void content, leading to higher tensile and flexural strengths, but excessively small heights can cause processing issues.
What is the significance of extrusion temperature in FFF of CFRP?
Extrusion temperature influences the viscosity of the polymer matrix and the wetting of carbon fibers. An optimal temperature ensures good fiber-matrix adhesion without thermal degradation.
Can the findings be applied to other fiber types?
While the study focuses on carbon fibers, the methodology and trends may be transferable to other continuous fiber composites, though specific optimal parameters may vary.
What are the main defects in 3D-printed CFRP composites?
Common defects include voids, poor fiber-matrix adhesion, and fiber misalignment, which can be mitigated through process parameter optimization.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.